首页 News 正文

While pharmaceutical giants are still fiercely competing over GLP-1 weight loss drugs, Danish pharmaceutical giant Novo Nordisk has already set its sights on developing drugs to prevent obesity.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

六月清晨搅 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    30